Top Markets
Coin of the day
Zynerba Pharmaceuticals, Inc. Zynerba Pharmaceuticals, Inc.

Zynerba Pharmaceuticals, Inc.

ZYNE
Kedudukan dalam Saham #26763
Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in... Zynerba Pharmaceuticals, Inc. is a specialized pharmaceutical firm currently in the clinical development phase. Its primary objective is to create and advance medicinal transdermal cannabinoid treatments specifically for uncommon and scarcely encountered neuropsychiatric conditions. A key product in its pipeline is Zygel, a pharmaceutical-grade cannabidiol expertly crafted into a gel with enhanced skin penetration for topical application. Originally established as AllTranz, Inc., the company adopted its current name, Zynerba Pharmaceuticals, Inc., in August 2014. Founded in 2007, Zynerba Pharmaceuticals maintains its headquarters in Devon, Pennsylvania.
Harga Saham
$1.30
Disegerakkan terakhir: 2023-10-13
Modal Pasaran
$38.02M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Zynerba Pharmaceuticals, Inc. (ZYNE)

Kategori

Sejarah harga saham bagi Zynerba Pharmaceuticals, Inc. (ZYNE)
Harga penutupan tertinggi: $1.27 pada 2023-10-01

Harga penutupan terendah: $28.18 pada 2015-08-01
Sejarah harga saham Zynerba Pharmaceuticals, Inc. dari 2015 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2023 121.20%
2022 -82.15%
2021 -16.92%
2020 -34.43%
2019 51.25%
2018 -67.91%
2017 -17.16%
2016 20.03%
2015 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
$171.67 -
DE
$163.21 25.45%
DE
$38.00 22.72%
JP
$220.18 33.00%
CH
$21.01 11.96%
IN